Address
Email address
Phone number
Website
https://www.pharmasynth.eePharmaSynthPET/SPECT precursors, reference standards and auxiliary reagents in GMP grade.
Name
PharmaSynth AS
Registry code
11044101
VAT number
EE100940196
Type
AS - Joint Stock Company
Status
Registered
Foundation date
29.06.2004 (21)
Financial year
01.01-31.12
Capital
57 180.00 €
Activity
21101 - Manufacture of basic pharmaceutical products
586 714 €
152 148 €
26%
2 992 €
(estimate is approximate)
1 048 392 €
8
Submitted
No tax arrears
15%
14%
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Jukka Veli Hiltunen
| - | - | Direct ownership |
| Pirkko-Irene Penttilä-Hiltunen
| - | Board member | - |
| Heli Väärtnõu-Järv
| 11% - 6 180.00 EUR | - | - |
| SILLAMATSI MEDICAL OÜ 10913017 | 49% - 28 140.00 EUR | - | - |
| Omanikukonto: ANTTI OLAVI ROSLAKKA
| 25% - 14 040.00 EUR | - | - |
| 2019 05.10.2020 | 2020 05.08.2021 | 2021 02.03.2023 | 2022 21.06.2023 | 2023 26.06.2024 | 2024 30.06.2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | 319 371 € | 444 406 € | 510 772 € | 475 618 € | 635 352 € | 586 714 € |
| Net profit (loss) for the period | 42 880 € | 199 141 € | 247 819 € | 121 436 € | 145 484 € | 152 148 € |
| Profit Margin | 13% | 45% | 49% | 26% | 23% | 26% |
| Current Assets | 213 484 € | 398 964 € | 588 770 € | 635 684 € | 783 422 € | 968 754 € |
| Fixed Assets | 25 598 € | 38 269 € | 90 310 € | 197 667 € | 157 357 € | 154 963 € |
| Total Assets | 239 082 € | 437 233 € | 679 080 € | 833 351 € | 940 779 € | 1 123 717 € |
| Current Liabilities | 45 479 € | 55 728 € | 49 756 € | 82 591 € | 44 535 € | 75 325 € |
| Non Current Liabilities | 11 239 € | 0 € | - | - | - | - |
| Total Liabilities | 56 718 € | - | - | - | - | - |
| Share Capital | 60 908 € | 60 908 € | 60 908 € | 60 908 € | 57 180 € | 57 180 € |
| Equity | 182 364 € | 381 505 € | 629 324 € | 750 760 € | 896 244 € | 1 048 392 € |
| Employees | 8 | 7 | 7 | 7 | 7 | 8 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | 598 886 € | 45 240 € | 48 589 € | 11 |
| 2025 Q3 | 76 881 € | 43 134 € | 46 593 € | 11 |
| 2025 Q2 | 204 706 € | 36 887 € | 39 265 € | 10 |
| 2025 Q1 | 193 572 € | 44 449 € | 47 436 € | 9 |
| 2024 Q4 | 144 888 € | 39 879 € | 42 231 € | 9 |
| 2024 Q3 | 188 774 € | 34 016 € | 35 984 € | 9 |
| 2024 Q2 | 105 109 € | 33 098 € | 35 258 € | 8 |
| 2024 Q1 | 139 707 € | 31 248 € | 32 989 € | 8 |
| 2023 Q4 | 102 827 € | 30 656 € | 32 096 € | 8 |
| 2023 Q3 | 189 320 € | 30 191 € | 31 857 € | 8 |
| 2023 Q2 | 144 998 € | 34 125 € | 36 061 € | 8 |
| 2023 Q1 | 194 811 € | 30 068 € | 31 743 € | 8 |
| 2022 Q4 | 139 706 € | 24 295 € | 25 556 € | 8 |
| 2022 Q3 | 108 932 € | 19 036 € | 19 929 € | 8 |
| 2022 Q2 | 113 668 € | 16 704 € | 15 588 € | 8 |
| 2022 Q1 | 124 229 € | 19 012 € | 20 015 € | 7 |
